Washington DC-based private equity firm The Halifax Group has hired Charles Alutto from Stericycle as operating executive. Alutto will evaluate the firm’s specific investment opportunities and assist in validating its investment thesis.
Alutto was president and CEO at Stericycle, a $3.6bn publicly traded company in the medical waste space which he spent 22 years. He grew the company’s US and European operations and oversaw its M&A strategy.
Doug Hill, Halifax senior partner, said, “We have been impressed with Charlie since our first introduction, and he has already made meaningful contributions helping us evaluate specific new investments and serving as an independent board director. We are pleased to formalize his association with our firm as we continue to enhance our value creation strategies.
“Charlie’s experience with team building and strategic planning will make him a valued collaborator and independent resource as we work with owners and managers to support entrepreneurial companies across all of our investment theses.”
The Halifax Group targets lower middle-market businesses with total enterprise values generally between $50 million and $300 million.
It is currently investing out of Halifax Capital Partners IV, a $650m vehicle it closed in 2017.
The firm promoted David Bard to partner in July after three years with the investment house and named operating executive and former RLJ Equity Partners founding member Jerry Johnson as a partner earlier in the year.
Copyright © 2021 AltAssets